unknown
Stage
1
Investors
About
Dot Lab develops DotEndo, a non-invasive blood test that uses biomarkers and biostatistics to aid in the diagnosis of active endometriosis across all stages of the disease.
Explore Dot Lab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.